A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Known as Reagila in the UK
Sign up to get notified once we do.
Vraylar is effective at treating thought and mood disorders. It works by modulating the effects of dopamine in the brain.
The usual starting dose of Vraylar is 1.5 mg once daily.
Your doctor may increase your dose to 1.5-6 mg once daily, depending on the condition being treated.
Take Vraylar exactly as prescribed by your doctor.
The active ingredient in Vraylar is cariprazine.
Vraylar has many potential drug-drug interactions, including:
Vraylar and other antipsychotic medications should not be used to treat dementia-related psychosis in older adults.
Tell your doctor if you experience suicidal thoughts or behaviors while taking Vraylar.
Tell your doctor if you have a history of kidney or liver problems.
Use with caution if you have a history of seizure disorders.
The most common side effects with Vraylar may include:
Vraylar [package insert]. Parsippany, NJ: Actavis; 2015.